USE OF THIOTRIAZOLIN IN THE TREATMENT OF ISCHEMIC HEART DISEASE

Authors

  • Rajabova N. T. PhD, Senior Lecturer, Department of Pediatrics and Higher Nursing, Urgench Branch of TMA, Urgench, Uzbekistan
  • Kilicheva T. A. Assistant of the Department of Propaedeutics of Pediatric Diseases, Urgench Branch of TMA, Urgench, Uzbekistan

Keywords:

Ischemic heart disease, patients, cardioprotection, thiotriazoline, different forms.

Abstract

The article deals with the issues of research of cardioprotective effect of thiotriazolin drug in patients with different firms (RF) of coronary heart disease (CHD). At inclusion in complex treatment (CT) of patients with RF CHD tiotriazolin improvement of a condition is reached in shorter terms and gives good distant results. Cardioprotective drug with metabolic and antioxidant type of action - thiotriazolin - significantly increases the effectiveness of baseline therapy of CHD.

Downloads

Published

2024-01-16

Issue

Vol. 18 (2024)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

USE OF THIOTRIAZOLIN IN THE TREATMENT OF ISCHEMIC HEART DISEASE. (2024). Neo Scientific Peer Reviewed Journal, 18, 10-13. https://neojournals.com/index.php/nspj/article/view/363

Most read articles by the same author(s)